经动脉化疗栓塞术 (TACE) 联合或不联合仑伐替尼+帕博利珠单抗治疗中晚期肝细胞癌 :Ⅲ期LEAP-012研究 汇报专家:Josep Llovet (Barcelona, Spain) 演讲时间:9月14日17:30 - 17:42 口头报告专场1:消化肿瘤-上消化道 地点:Sevilla Auditorium -...
2024年欧洲肿瘤内科学会年会(ESMO)将于2024年9月13日至17日在巴塞罗那举行,ESMO 大会是对来自世界各地的临床医生、研究人员、患者权益倡导者、记者和医疗保健行业代表最具影响力的肿瘤学平台。ESMO 2024 将传播最新的前沿数据,为来自世界各地的肿瘤学家和其他利益相关者提供高质量的教育和无与伦比的交流机会。E 请...
ESMO World GI 2024 ESMO 26th World Congress on Gastrointestinal Cancer Dates: 7/3/2024 - 7/6/2024 Venue: CCIB, Barcelona, Spain 第26 届世界胃肠癌大会是今年最重要的聚会,旨在扭转当前将胃肠道恶性肿瘤列为全球癌症死亡主要原因之一的全球统计数据。作为该领域的首要全球活动,大会汇集了来自全球各地的领先...
Mini oral session 2: Breast cancer, metastatic 日期:2024年9月16日 时间:08:30 - 10:00 主席:Carmen Criscitiello (Milan, Italy) Sandra Ximena Franco Millan (Bogota, Colombia) 地点:Barcelona Auditorium - Hall 2 347MO - The safety and efficacy of ivonescimab in combination with chemotherapy as...
https://cslide.ctimeetingtech.com/esmo2024/attendee/confcal/show/session/7 日期:2024 年 9 月 13 日,星期五 时间:12:00 - 13:45(北京时间:18:00 - 19:45) 地点:Barcelona Auditorium - Hall 2 图1. 具体每位获奖者颁奖时间 ESMO 四...
1. Rha SY, Lee KW, Lee S, et al. Zanidatamab plus chemotherapy in first-line human epidermal growth factor receptor 2-positive (HER2+) advanced/metastatic colorectal cancer (mCRC). Presented at: 2024 ESMO Congress; September 13-17, 2024; Barcelona, Spain. Abstract 516MO. ...
ESMO 2024 Congress Metabolon is proud to announce its participation at the upcoming ESMO 2024 Congress in Barcelona, Spain. As a leading provider of metabolomics solutions, Metabolon recognizes the importance of engaging with the global oncology community to advance research and innovation in cancer ...
日期:2024年9月13日 时间:16:00 - 17:30 主席:Christos Sotiriou (Brussels, Belgium) Karen A. Gelmon (Vancouver, Canada, British Columbia) 地点:Barcelona Auditorium - Hall 2 LBA18 - Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ advanced/metastatic breast cancer (mBC) with or...
日期:2024年9月13日 时间:16:00 - 17:30 主席:Christos Sotiriou (Brussels, Belgium) Karen A. Gelmon (Vancouver, Canada, British Columbia) 地点:Barcelona Auditorium - Hall 2 LBA18 - Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ advanced/metastatic breast cancer (mBC) with or...
Venue: International Barcelona Convention Centre, Barcelona, SpainThe ESMO Gastrointestinal Cancers Congress 2025 will take place from 2 to 5 July in Barcelona, Spain, as well as online, through a dedicated virtual platform. This important event will bring together leading experts, researchers, and...